semaglutide and diverticulosis Ozempic Diverticulitis: Exploring the Possible Link Should I hold my next

This way, you could work your way up to a brisk walk every day

avoid areas with bruising, scarring, or lipohypertrophy, as these impair drug absorption

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

The aim was to assess the prevalence of hyperglycaemia in people treated with systemic glucocorticoids for COPD

Responsive Care: Fast, helpful support when you need it